WHO Report Projects Cancer Cases Will Nearly Double Worldwide by 2050
The World Health Organization (WHO) Global Status Report on Cancer 2026, released on July 8, 2026, projects that, without urgent action, new annual cancer cases will nearly double, from the current 20.6 million to nearly 35 million by 2050. While heart disease remains the leading cause of death worldwide, cancer ranks second. The WHO attributes […]
Meningococcal B Vaccine Fails to Protect Against Gonorrhea
A new randomized controlled trial (RCT) published in the New England Journal of Medicine (NEJM) has found that the Meningitis B vaccine does not prevent gonorrhea infections despite a year-long mass vaccination campaign targeting at-risk men in the United Kingdom. After gonorrhea cases exceeded the highest levels ever recorded, the U.K.’s National Health Service (NHS) […]
CDC Again Changes Wording About Vaccines and Autism
Before Nov. 19, 2025, the U.S. Centers for Disease Control and Prevention (CDC) featured language on its website declaring point blank that vaccines do not cause autism. Specifically, at that time the CDC stated: “Studies have shown that there is no link between receiving vaccines and developing autism spectrum disorder (ASD). No links have been […]
Nominee for CDC Head Questioned by Senate Health Committee
President Trump’s nominee to be director of the U.S. Centers for Disease Control and Prevention (CDC) underwent questioning at a hearing of the Senate Health, Education, Labor, and Pensions (HELP) Committee. on July 15, 2026. Erica Schwartz, MD, JD, MPH was repeatedly asked questions regarding her views on vaccines, how they contrast with those of […]
CDC Just Awarded Pfizer $1.2 Billion for COVID-19 Shots
U.S. federal procurement records published in June 2026 show that the U.S. Centers for Disease Control and Prevention (CDC) awarded Pfizer more than $1.24 billion in contracts for adult and pediatric mRNA COVID-19 shots for fiscal years 2026 and 2027. The contracts, which were published on SAM.gov and contained more money allocated for pediatric COVID […]
Experimental Vaccine to Prevent Fentanyl Overdose Enters Human Trials
An experimental “anti-fentanyl” vaccine developed by ARMR Sciences, Inc. of New York and the University of Houston has entered Phase 1/2 human trials, according to a June 17 press release issued by the company. The vaccine candidate has spent years in development and vaccine developers say it represents a potential intervention in America’s ongoing overdose […]